Israel Marks Breakthrough Moment with Historic Artificial Heart Transplants

The human heart is an incredible and powerful organ. It supplies blood to the entire body, keeping us alive, and can adapt its rhythm as needed based on physical activity. Now, scientists are replicating this natural wonder and creating life-sustaining artificial hearts.

In a major development, Israel has completed its first two artificial heart transplants, The Times of Israel reports. It’s a medical breakthrough that could save lives.

Life-Saving Treatments
The first successful artificial heart transplant took place at Hadassah Ein Kerem Hospital in Jerusalem, while the second occurred just four days later at Sheba Tel-HaShomer Medical Center in Ramat Gan. The promising surgeries saved the lives of two male patients — one in his 50s and the other in his 60s. Both had biventricular heart failure, a disease both the left and right ventricles of the heart were not pumping blood effectively.

According to ynet, up to 160 million people worldwide, including about 180,000 Israelis suffer from some form of heart failure. About ten percent of these patients have biventricular failure, a cardiac condition that could previously only be treated with a donor heart transplant.

Amid shortages for the organ, the artificial heart offers a life-saving solution to temporarily support patients until they can eventually receive a donor heart. “There simply aren’t enough hearts to go around,” Dr. Avi Morgan, surgical director of the Heart Transplant and Artificial Heart Unit at Sheba Medical Center, who performed the second surgery with Dr. Leonid Sternik and Dr. Eyal Nachum, told The Times of Israel.

Cutting-Edge Technology
The devices used in the procedures were Aeson artificial hearts, which were developed by the French medical company Carmat.  Aeson, the world’s most advanced artificial heart model, is a medical breakthrough. The Aeson artificial hearts used in the surgeries, were only used in 114 such procedures across the globe.

One benefit of the device is that in contrast to regular heart transplants, artificial hearts don’t carry the risk of rejection. The artificial heart is crafted from synthetic polymers and natural materials that are compatible with the human body, with valves and membranes made from cow heart tissue, to lower the possibility of blood clots. Furthermore, Aeson is designed to mimic the natural heart’s rhythm and adjust to the patient’s physical activity, ynet reports.

The device could offer hope to those with heart disease, with some patients living up to two years with the implant. Israel’s two recent transplants represent a significant global medical advancement. These cutting-edge procedures offer a new solution for patients with biventricular heart failure. With continued clinical success, artificial hearts could redefine the standard of care for patients with this condition.